Cover Image

Probiotic treatment with viable α‐galactosylceramide‐producing Bacteroides fragilis reduces diabetes incidence in female nonobese diabetic mice

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Camilla H. F. Hansen, Danica Jozipovic, Line F. Zachariassen, Dennis S. Nielsen, Axel K. Hansen, Karsten Buschard
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of sphingolipid enzymes on blood glucose levels, development of diabetes, and involvement of pericytes
by: Karsten Buschard, et al.
Published: (2024)

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
by: Filipe A. Moura, et al.
Published: (2024)

An estimate of the need for continuous glucose monitoring in type 2 diabetes with intensive insulin treatment in secondary healthcare
by: Christian Trolle, et al.
Published: (2024)

Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors
by: Viktor Rotbain Curovic, et al.
Published: (2024)

Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022
by: Line Davidsen, et al.
Published: (2025)

SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in type 2 diabetes mellitus
by: Mark Luedde, et al.
Published: (2025)

Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate‐protein kinase G signaling in diabetic mice
by: Shengping Lei, et al.
Published: (2024)

Association of carpal tunnel syndrome with incident diabetes
by: Jeppe Ravn Jacobsen, et al.
Published: (2024)

Sodium–glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real‐world, cohort data
by: Alex E. Henney, et al.
Published: (2024)

Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
by: Yaxin Wang, et al.
Published: (2024)

Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study
by: Abhilasha Akerkar, et al.
Published: (2025)

Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams
by: Mikkel Thor Olsen, et al.
Published: (2025)

Accelerated onset of diabetes in non‐obese diabetic mice fed a refined high‐fat diet
by: Heidi M. Batdorf, et al.
Published: (2024)

Gut microbiota‐mediated branched‐chain amino acid metabolism: A novel mechanism by which Bacteroides uniformis improves type 2 diabetes mellitus
by: Yuefeng Zhang, et al.
Published: (2026)

THR1VE!: Randomized controlled trial to reduce diabetes distress in adolescents with type 1 diabetes
by: Sarah S. Jaser, et al.
Published: (2025)

The diabetes body project: Study protocol of a multi‐site trial of a virtually delivered eating disorder prevention program for young women with type 1 diabetes
by: Severina Haugvik, et al.
Published: (2024)

Type 2 diabetes in Norway 2009–2021: Have declining incidence rates continued?
by: Lars Bakke Hindenes, et al.
Published: (2026)

Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus
by: Ching‐Kit Tsui, et al.
Published: (2025)

Protocol for a 1‐year randomised, controlled, parallel group, open‐label trial on the effects and feasibility of time‐restricted eating in individuals with type 2 diabetes‐ The REStricted Eating Time in the treatment of type 2 diabetes (RESET2) trial
by: Anne‐Ditte Termannsen, et al.
Published: (2025)

Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis
by: Leonardo A. Mesquita, et al.
Published: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
by: Iskandar Idris
Published: (2024)

The effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: A systematic review and meta‐analysis
by: Rebecca A. Dennison, et al.
Published: (2024)

Commentary on “Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus”
by: Fatemeh Rasulpur, et al.
Published: (2025)

No COVID ‐19 pandemic‐associated increase of childhood type 1 diabetes incidence in Western Australia
by: Ewan Cameron, et al.
Published: (2025)

Group‐based interventions to reduce diabetes distress in adults with type 1 diabetes: A rapid realist review of the Reduce and TunedIn interventions
by: Sarah Sims, et al.
Published: (2026)

Mechanisms underlying the development of eating disorders and disordered eating in adolescent females with type 1 diabetes
by: Caroline Bruun Abild, et al.
Published: (2024)

Risk factor control and incident cardiovascular disease in patients with diabetes: Sex‐specific relations
by: Xuan Wang, et al.
Published: (2024)

Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
by: Fumika Kamitani, et al.
Published: (2024)

Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank
by: Seyedeh Forough Sajjadi, et al.
Published: (2024)

Arterial stiffness and atherosclerosis and incident cardiovascular events and all‐cause mortality in individuals with manifest cardiovascular disease with and without type 2 diabetes
by: Jan F. de Leijer, et al.
Published: (2025)

Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus
by: Ida M. Gether, et al.
Published: (2024)

Changes in remnant cholesterol and the incidence of diabetes: Results from two large prospective cohort studies
by: Yue Shao, et al.
Published: (2025)

Age‐specific incidence and prevalence of childhood type 1 diabetes: Development over four decades in Southwest Germany
by: Julian Ziegler, et al.
Published: (2026)

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial
by: David S. Mathiesen, et al.
Published: (2025)

Interleukin‐37 promotes wound healing in diabetic mice by inhibiting the MAPK/NLRP3 pathway
by: Qiaoli Cui, et al.
Published: (2024)

High co‐incidence of coeliac disease in paediatric type 1 diabetes: A call for systematic screening
by: Giulio Maltoni, et al.
Published: (2025)

Hands in diabetes
by: Rowan Hillson
Published: (2024)

The stomach in diabetes
by: Rowan Hillson
Published: (2024)

Housing and diabetes
by: Rowan Hillson
Published: (2024)

Beta‐cell activity and development of Type 1 diabetes
by: Rikke Thea, et al.
Published: (2024)